Compare Kaia (KAIA) vs Enzyme (MLN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kaia vs Enzyme — how do they compare? Kaia trades at Rp452.43 (market cap Rp2,89T, Rp56,42M 24h volume), while Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume). The key difference: Kaia is far larger — about 21546.3× Enzyme's market cap, and Kaia's circulating supply is 6,4B KAIA versus 3,3M MLN for Enzyme. Which is the better fit depends on your goals — on Pluang, investors hold Kaia for 30 Days and Enzyme for 29 Days on average.
| KAIA | MLN | |
|---|---|---|
Market Cap | Rp2,89T | Rp134,13M |
Volume (24h) | Rp56,42M | Rp104,56M |
Circulating Supply | 6,4B KAIA | 3,3M MLN |
Typical Hold Time | 30 Days | 29 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Kaia is currently trading at Rp461.8 with a market cap of Rp2.95T, showing bearish technical signals across moving averages and oscillators. The token faces resistance at Rp464 (pivot point) with support at Rp458. RSI indicators suggest neutral momentum while ADX signals strong bearish trends. No recent protocol updates or ecosystem developments were identified in current market data.
Overall outlook remains cautious with technical indicators heavily favoring sellers. Key opportunities include potential bounce from support levels, while major risks include continued bearish momentum and limited liquidity. Investors should monitor for any ecosystem developments that could shift sentiment.
Enzyme (MLN) shows limited market activity with a modest market cap of Rp134,13M and circulating supply of 3,3jt tokens. The asset demonstrates relatively low volatility with an average hold time of 29 days, suggesting stable holder behavior. Trading volumes appear subdued across exchanges, indicating limited speculative interest. No significant protocol upgrades or ecosystem developments have been reported recently, though the project continues to operate its decentralized asset management platform.
Overall outlook remains cautious due to limited liquidity and trading activity. Key opportunities include potential ecosystem growth in decentralized finance asset management, while major risks include low market depth, regulatory uncertainty for DeFi protocols, and competition from larger DeFi platforms. The token's utility within its native protocol remains its primary value driver.
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Kaia
Kaia is a high-performance public blockchain that brings Web3 to the fingertips of millions across Asia. It was formed through the merger of the Klaytn and Finschia blockchains, initially developed by Kakao and LINE, respectively. Kaia represents Asia's largest Web3 ecosystem, seamlessly integrated with the KakaoTalk and LINE messaging platforms, which boast a combined user base of over 250 million. This allows users to experience Web3 with the ease and speed of Web2, all within their favorite super apps, enabling them to connect, create, collaborate, and contribute to the ecosystem.
Read more on KAIA →About Enzyme
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →
